Video

Dr Melinda Magyari Addresses the Use of Disease-Modifying MS Therapies in Children

Melinda Magyari, MD, PhD, consultant neurologist, the Danish Multiple Sclerosis Center, Copenhagen University Hospital, addresses the current state of knowledge on using disease-modifying therapies to treat children with multiple sclerosis (MS).

Melinda Magyari, MD, PhD, consultant neurologist, the Danish Multiple Sclerosis Center, Copenhagen University Hospital, addresses the current state of knowledge on using disease-modifying therapies to treat children with multiple sclerosis (MS).

Transcript

What is the current understanding about how to use disease-modifying therapies in children and adolescents with MS?

We don’t know a lot about it. This was my question looking at my own registry. I haven't really seen many similar studies published from other countries to see whether those not-existing guidelines has been interpreted the same way as we did in Denmark. So it would, I would encourage everybody having a cohort registry to publish these data.

Related Videos
Eboni Price-Haywood, MD, and Toni Flowers, PhD
Tom Belmon, CAP, GPBCH
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Tom Belmont
Pieter Sonneveld, MD, PhD
Mohit Narang, MD
 Sandeep Sahay, MD, FCCP, director of the Pulmonary Hypertension Program, Houston Methodist Hospital
Jessica Horwitz, MPH, FNP-C.
Jessica Horwitz, MPH, FNP-C.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo